Articles with "pnet" as a keyword



Ewing sarcoma/primitive neuro-ectodermal tumor of the urogenital system in children: a retrospective observational case series.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of pediatric urology"

DOI: 10.1016/j.jpurol.2019.06.022

Abstract: INTRODUCTION Pediatric Ewing sarcoma (ES)/primitive neuro-ectodermal tumor (PNET) occurring in the genitourinary system has been rarely reported. And the result of long-term follow-up is still a matter of debate. OBJECTIVE The aim of the study… read more here.

Keywords: system; neuro ectodermal; primitive neuro; pnet ... See more keywords

Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors

Sign Up to like & get
recommendations!
Published in 2024 at "British Journal of Cancer"

DOI: 10.1038/s41416-023-02565-8

Abstract: Pancreatic neuroendocrine tumors (PNETs) with low microvessel density and fibrosis often exhibit clinical aggressiveness. Given the contribution of cancer-associated fibroblasts (CAFs) to the hypovascular fibrotic stroma in pancreatic ductal adenocarcinoma, investigating whether CAFs play a… read more here.

Keywords: cancer; pnet; metastasis; cafs ... See more keywords

Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-13847-6

Abstract: Various inflammation-based prognostic scores have been associated with reduced survival in patients with nonfunctional pancreatic neuroendocrine tumor (NF-PNET). However, few studies have illuminated the relationship between the preoperative gamma-glutamyltransferase (GGT) to lymphocyte ratio index (GLRI)… read more here.

Keywords: pancreatic neuroendocrine; nonfunctional pancreatic; glri; curative resection ... See more keywords

Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study

Sign Up to like & get
recommendations!
Published in 2022 at "Gastroenterology Report"

DOI: 10.1093/gastro/goad010

Abstract: Abstract Background and objective The value of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumor (m-PNET) remains poorly defined. This study aimed to evaluate the outcomes of m-PNET following debulking surgery in our institute.… read more here.

Keywords: surgery; pnet; resection; debulking surgery ... See more keywords

ETMR-15. RECLASSIFICATION OF CHILDHOOD CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR: CLINICAL FEATURES AND OUTCOME

Sign Up to like & get
recommendations!
Published in 2024 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noae064.185

Abstract: Abstract BACKGROUND The “central nervous system primitive neuroectodermal tumor” (CNS-PNET) nosology was removed from the World Health Organization (WHO) classification after DNA methylation profiling and new tumor entities characterized by specific recurrent genetic alterations were… read more here.

Keywords: central nervous; nervous system; pnet; nosology ... See more keywords

Circulating Chromogranin A Is Associated With Disease Extent, Progression, and Recurrence in Patients With Nonfunctioning Pancreatic Neuroendocrine Tumor

Sign Up to like & get
recommendations!
Published in 2024 at "Pancreas"

DOI: 10.1097/mpa.0000000000002428

Abstract: Objectives: Nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) are rare tumors with heterogeneous biology. Radiology and serum biomarkers are used for postresection surveillance; however, no universally established protocol exists. Serum chromogranin A (CgA) concentration is elevated in… read more here.

Keywords: disease; pancreatic neuroendocrine; pnet; surveillance ... See more keywords
Photo from wikipedia

c‐Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Science"

DOI: 10.1111/cas.14717

Abstract: Pancreatic neuroendocrine tumor (pNET) is a pancreatic neoplasm with neuroendocrine differentiation. pNET in early stage can be treated with surgical resection with long‐term survival, whereas the prognosis of pNET with locoregional or distant metastasis is… read more here.

Keywords: tumor; node metastasis; metastasis; lymph node ... See more keywords

Abstract B009: Identifying of a novel diagnostic markers for pancreatic neuroendocrine tumors by proteomics with patient blood

Sign Up to like & get
recommendations!
Published in 2024 at "Cancer Research"

DOI: 10.1158/1538-7445.panca2023-b009

Abstract: Neuroendocrine tumors are tumors originating from endocrine cells in various organs, and present very heterogeneous characteristics, and the incidence rate is gradually increasing. Among them, neuroendocrine tumors originating from pancreas are divided into functional tumors… read more here.

Keywords: diagnosis; identifying novel; pancreatic neuroendocrine; pnet ... See more keywords

Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1

Sign Up to like & get
recommendations!
Published in 2017 at "Molecular Cancer Research"

DOI: 10.1158/1541-7786.mcr-16-0285

Abstract: Doublecortin-like kinase 1 (DCLK1), a marker for intestinal and pancreatic cancer stem cells, is highly expressed in neuroblastomas. This study was conducted to assess DCLK1 expression levels in pancreatic neuroendocrine tumor (PNET) tissues and to… read more here.

Keywords: pancreatic neuroendocrine; cancer; marker dclk1; marker ... See more keywords

Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration

Sign Up to like & get
recommendations!
Published in 2022 at "JCI Insight"

DOI: 10.1172/jci.insight.160130

Abstract: Pancreatic neuroendocrine tumors (PNETs) are malignancies arising from the islets of Langerhans. Therapeutic options are limited for the over 50% of patients who present with metastatic disease. We aimed to identify mechanisms to remodel the… read more here.

Keywords: cell; metastatic pnets; pnet; neuroendocrine tumors ... See more keywords

RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Investigation"

DOI: 10.1172/jci123049

Abstract: Hyperactivated AKT/mTOR signaling is a hallmark of pancreatic neuroendocrine tumors (PNETs). Drugs targeting this pathway are used clinically, but tumor resistance invariably develops. A better understanding of factors regulating AKT/mTOR signaling and PNET pathogenesis is… read more here.

Keywords: phosphorylation; pnet; akt; rabl6a ... See more keywords